Clinical Trial Update: GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of GA101-miniCHOP regimen for elderly unfit patients with CD20-positive diffuse large B-cell lymphoma; study terminated with results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• GA101-miniCHOP (obinutuzumab-based regimen? (GA101 is obinutuzumab))

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: CD20 Positive Diffuse Large B-cell Lymphoma, Elderly Unfit Patients | Phase 2 | Status: TERMINATED | Results posted: 2020-11-05